Ironwood Pharmaceuticals Inc. Cl A | Key People and Executives
Peter M. Hecht
Chief Executive Officer & Director
Terrance G. McGuire
Chairman
Andrew Dreyfus
Independent Director
Amy W. Schulman
Independent Director
Douglas E. Williams
Independent Director
Edward P. Owens
Independent Director
Marsha H. Fanucci
Independent Director
Julie Harris McHugh
Independent Director
Lawrence S. Olanoff
Independent Director
Peter M. Hecht
Chief Executive Officer & Director
William I. Huyett
Chief Operating Officer
Gina R. Consylman
CFO, CAO, Controller & SVP-Finance
Brian M. Cali
Senior VP-Preclinical, Research & Development
Mark G. Currie
Chief Scientific Officer & Senior Vice President
Michael L. Hall
Senior Vice President-Clinical Development
Christopher I. Wright
Chief Development Officer & SVP-Global Development
Thomas A. McCourt
Chief Commercial Officer, SVP-Sales & Marketing
Meredith Kaya
VP-Investor Relations & Corporate Communications
Jonathan Rosin
Vice President-Human Resources
Halley E. Gilbert
Secretary, Chief Legal Officer & Senior VP
Terrance G. McGuire
Chairman
Andrew Dreyfus
Independent Director
Amy W. Schulman
Independent Director
Douglas E. Williams
Independent Director
Edward P. Owens
Independent Director
Marsha H. Fanucci
Independent Director
Julie Harris McHugh
Independent Director
Lawrence S. Olanoff
Independent Director
| Address |
301 Binney Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.ironwoodpharma.com |
| Updated |
07/08/2019 |
| Ironwood Pharmaceuticals, Inc. operates as commercial biotechnology company, which discovers, develops and commercializes differentiated medicines that improve patient's lives. Its products include linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with irritable bowel syndrome with constipation and chronic constipation; and lesinurad for the treatment of hyperuricemia associated with uncontrolled gout. The company was founded by Peter M. |
